Arbutus Biopharma Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABUS Nasdaq 2836 www.arbutusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arbutus Biopharma Corporation

Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’ - Jan 16th, 2025 4:22 pm
Kymera Therapeutics (KYMR) Moves 7.8% Higher: Will This Strength Last? - Jan 15th, 2025 2:38 pm
Arbutus Provides 2025 Corporate and Financial Update - Jan 13th, 2025 12:30 pm
Here’s Why Arbutus (ABUS) Surged in Q3 - Dec 6th, 2024 1:20 pm
Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - Dec 3rd, 2024 1:00 pm
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - Nov 26th, 2024 12:30 pm
Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon - Nov 15th, 2024 4:02 pm
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B - Nov 15th, 2024 4:01 pm
Arbutus to Present at Jefferies London Healthcare Conference - Nov 14th, 2024 12:30 pm
Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ... - Nov 7th, 2024 7:12 am
Q3 2024 Arbutus Biopharma Corp Earnings Call - Nov 7th, 2024 7:07 am
Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2024 1:45 pm
Arbutus: Q3 Earnings Snapshot - Nov 6th, 2024 12:40 pm
Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Nov 6th, 2024 12:30 pm
Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Oct 23rd, 2024 11:30 am
Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024 - Oct 15th, 2024 12:16 pm
Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference - Oct 1st, 2024 11:30 am
Has Arbutus Biopharma (ABUS) Outpaced Other Medical Stocks This Year? - Sep 25th, 2024 1:40 pm
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year? - Sep 9th, 2024 1:40 pm
Arbutus to Participate in Two Upcoming Investor Conferences - Sep 3rd, 2024 11:30 am